Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.06 Insider Own0.20% Shs Outstand144.23M Perf Week0.00%
Market Cap477.40M Forward P/E- EPS next Y-0.70 Insider Trans346.67% Shs Float141.42M Perf Month10.33%
Income0.40M PEG- EPS next Q-0.12 Inst Own100.00% Short Float12.75% Perf Quarter8.52%
Sales70.50M P/S6.77 EPS this Y109.60% Inst Trans0.84% Short Ratio10.63 Perf Half Y-35.48%
Book/sh0.04 P/B82.75 EPS next Y-20.70% ROA0.20% Target Price9.17 Perf Year-47.63%
Cash/sh0.83 P/C3.98 EPS next 5Y10.00% ROE1.40% 52W Range2.38 - 8.04 Perf YTD-21.56%
Dividend- P/FCF- EPS past 5Y15.40% ROI- 52W High-58.77% Beta2.08
Dividend %- Quick Ratio3.60 Sales past 5Y-0.70% Gross Margin56.10% 52W Low39.29% ATR0.17
Employees156 Current Ratio3.60 Sales Q/Q31.60% Oper. Margin-7.80% RSI (14)59.18 Volatility5.60% 5.04%
OptionableYes Debt/Eq18.71 EPS Q/Q-162.90% Profit Margin0.60% Rel Volume1.09 Prev Close3.31
ShortableYes LT Debt/Eq18.71 EarningsMay 03 BMO Payout0.00% Avg Volume1.70M Price3.32
Recom1.40 SMA204.97% SMA5012.39% SMA200-21.80% Volume1,285,049 Change0.15%
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
May-03-16 09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:46AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:16AM  Array BioPharma reports 3Q loss AP
08:00AM  Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016 PR Newswire
07:07AM  Q3 2016 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Apr-26-16 12:25PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016 PR Newswire
Apr-25-16 09:36AM  Why Patents are the Lifeblood of Biotech Companies Accesswire
Apr-17-16 05:17PM  Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study at TheStreet
Apr-01-16 09:41AM  Array Bio ends late-stage study of ovarian cancer drug Reuters
09:16AM  Array Bio stops study testing drug for ovarian cancer Reuters
09:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer PR Newswire
Mar-31-16 09:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization Collaboration For Novel Pain And Inflammation Program PR Newswire
Mar-24-16 03:51PM  Five Cheap Healthcare Stocks With Hedge Fund Support at Insider Monkey +5.15%
Mar-23-16 08:28AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : March 23, 2016 -7.48%
Mar-09-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 9, 2016
Mar-08-16 08:47AM  Array Biopharma draws upside position -6.33%
Mar-01-16 12:53PM  Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference PR Newswire +6.77%
Feb-29-16 05:05AM  Edited Transcript of ARRY earnings conference call or presentation 3-Feb-15 2:00pm GMT
Feb-16-16 09:00AM  Small Cap Acquisition Candidates See Increased Investor Interest Accesswire +8.02%
Feb-11-16 01:04PM  ARRAY BIOPHARMA INC Financials
Feb-08-16 08:00AM  Biotechnology Stocks Technical Review -- MannKind, Array BioPharma, Arena Pharma, and Chimerix Accesswire -9.97%
Feb-05-16 04:12PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
Feb-02-16 02:00PM  Edited Transcript of ARRY earnings conference call or presentation 2-Feb-16 2:00pm GMT
12:00PM  Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference PR Newswire
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
07:30AM  Array BioPharma reports 2Q loss
07:07AM  Q2 2016 Array Biopharma Inc Earnings Release - Before Market Open
07:04AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:00AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016 PR Newswire
Feb-01-16 12:21PM  Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma at noodls
11:55AM  Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma PR Newswire
Jan-27-16 02:00PM  Fate (FATE) to Move ProTmune into Phase I/II Study in Mid-16
Jan-26-16 02:52PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016 at noodls
02:31PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016 PR Newswire
Jan-13-16 09:02AM  5 Stocks Insiders Love Right Now at TheStreet -7.54%
Jan-12-16 01:07PM  Buffett, Starboard Among the Elite Investors to Disclose New Moves at Insider Monkey
Jan-11-16 04:05PM  QIAGEN Reaches Milestone With Portfolio of Master Collaboration Agreements for Pharma Companion Diagnostics PR Newswire
Jan-06-16 10:00AM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire -5.56%
08:33AM  Will Array BioPharma (ARRY) Crush Estimates at Its Next Earnings Report?
Dec-23-15 08:34AM  Why Array BioPharma (ARRY) Could Be Positioned for a Surge?
Dec-22-15 08:07AM  Array Reports Positive Results from Its Phase 3 Study
Dec-21-15 10:11AM  Array BioPharma, Inc. Earnings Analysis: Q1, 2016 By the Numbers
08:59AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : December 21, 2015
07:13AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Array Announces Closing Of Pierre Fabre Transaction PR Newswire
Dec-17-15 08:15AM  Array BioPharma (ARRY) Jumps: Stock Moves Up 20.6%
Dec-16-15 03:30PM  Array Biopharma (ARRY) Stock Spikes on Successful Drug Study at TheStreet +20.63%
01:02PM  Array's skin cancer drug succeeds in late-stage study
10:19AM  Why Are These Stocks Trending Today? at Insider Monkey
09:09AM  [$$] Array BioPharma Reports Successful Cancer Drug Trial at The Wall Street Journal
08:45AM  Array BioPharma Rallies on Late-Stage Win at 24/7 Wall St.
06:43AM  Array Biopharma melanoma drug succeeds in late-stage study
06:31AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:30AM  Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma PR Newswire
Dec-08-15 03:11PM  Here's Why Oncothyreon's Shares Pushed Higher in November at Motley Fool
08:33AM  Is Array BioPharma (ARRY) Stock a Solid Choice Right Now?
Dec-02-15 03:49PM  Fabrinet (FN) Attracting A Lot of Smart Money Attention at Insider Monkey
Dec-01-15 01:21PM  Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference PR Newswire
Nov-29-15 01:59PM  Hedge Funds Are Selling Off Iconix Brand Group Inc (ICON) at Insider Monkey
Nov-26-15 07:50AM  Is Array Biopharma Inc (ARRY) a Good Stock To Buy? at Insider Monkey
Nov-24-15 03:59PM  Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-23-15 06:04AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers
Nov-17-15 01:20PM  Array (ARRY)/Pierre Fabre Collaborate for Cancer Drugs
Nov-16-15 09:00AM  Array BioPharma Conference Call to Discuss the Development And Collaboration For Two Novel Oncology Products scheduled for 9:00 am ET today
07:32AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
07:30AM  Array BioPharma And Pierre Fabre Announce Development And Commercialization Collaboration For Two Novel Oncology Products, Binimetinib And Encorafenib PR Newswire
Nov-09-15 05:23PM  Array BioPharma To Present At The Stifel 2015 Healthcare And Jefferies 2015 Global Healthcare Conferences PR Newswire
Nov-06-15 07:54AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
Nov-04-15 08:20PM  Edited Transcript of ARRY earnings conference call or presentation 4-Nov-15 2:00pm GMT
02:03PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission o
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:29AM  Array BioPharma reports 1Q loss
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2016 PR Newswire
07:07AM  Q1 2016 Array Biopharma Inc Earnings Release - Before Market Open
Oct-30-15 08:19AM  Why biotech could be on the verge of a rebound
Oct-26-15 04:11PM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2016 On November 4, 2015 PR Newswire
Oct-07-15 08:30AM  5 Stocks Insiders Love Right Now at TheStreet
Oct-05-15 09:30AM  New Strong Buy Stocks for October 5th
Sep-28-15 09:00AM  Array Biopharma Inc Conference Call to Discuss the preliminary results from two melanoma trials and a colorectal cancer trial scheduled for 9:00 am ET today
08:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Clinical Data Presented On Binimetinib And Encorafenib In Melanoma PR Newswire
Sep-25-15 08:00AM  Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And Colorectal Cancer On September 28, 2015 PR Newswire
Sep-11-15 05:16PM  Redmile Group Does 360, Starts Selling Shares Of This Biotech at Insider Monkey
08:00AM  Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress PR Newswire
Sep-10-15 05:18PM  Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference PR Newswire
Sep-08-15 08:27AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:00AM  Array BioPharma Names Patricia Henahan As Chief Financial Officer PR Newswire
Sep-02-15 05:54PM  Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference PR Newswire +5.12%
Aug-26-15 12:50PM  Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In STAAR Surgical Company (STAA) at Insider Monkey
Aug-24-15 06:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Aug-23-15 08:09PM  10-K for Array BioPharma, Inc. at Company Spotlight
Aug-21-15 05:18PM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report
07:39AM  3 Low-Price Biotech Stocks That Could Pop or Drop in 2016 at Motley Fool
Aug-19-15 09:17AM  5 Stocks Insiders Love Right Now at TheStreet
Aug-15-15 09:15AM  Key Insider Buying in Twitter, Level 3, Sears, MBIA and More at 24/7 Wall St.
Aug-14-15 09:59AM  Redmile Group Is Putting More Money Into Array BioPharma Inc. (ARRY) at Insider Monkey
Aug-12-15 04:12AM  Bulls come back to Array BioPharma
Aug-11-15 12:32PM  Notable option activity in equities
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its drug candidates in Phase II clinical trials include Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASC08/Danoprevir, a protease inhibitor for Hepatitis C virus; ASLAN001/ARRY-543, a pan-HER inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; and LY2606368, a chk-1 inhibitor for cancer. The company's Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer; and ONT-380/ARRY-380, a HER2 inhibitor for breast cancer, as well as Phase I drug candidate includes GDC-0994, an ERK inhibitor for cancer and LOXO-101, a PanTrk inhibitor for cancer. Array BioPharma Inc. has collaboration agreements with Biogen Idec MA Inc.; Array and Celgene Corporation and Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc.; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc, as well as a collaboration with Dana-Farber Cancer Institute. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLC10% OwnerJan 12Buy3.6075,000270,00018,850,650Jan 14 04:14 PM
Redmile Group, LLC10% OwnerJan 11Buy3.54275,000973,50018,775,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 08Buy3.72350,0001,302,00018,500,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 07Buy3.73300,0001,119,00018,150,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerOct 01Buy4.50100,140450,63018,033,102Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 30Buy4.67182,452852,05117,932,962Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 29Buy4.56500,0002,280,00017,750,510Oct 01 07:15 PM
Sandor VictorChief Medical OfficerSep 22Option Exercise5.1895,891496,715138,659Sep 24 02:01 PM
Redmile Group, LLC10% OwnerAug 26Buy5.4849,900273,45217,250,510Aug 28 05:29 PM
Redmile Group, LLC10% OwnerAug 25Buy5.45220,0001,199,00017,200,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 24Buy5.32410,0002,181,20016,980,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 21Buy5.45160,000872,00016,570,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 12Buy5.93205,0001,215,65016,410,610Aug 13 07:16 PM
Redmile Group, LLC10% OwnerAug 11Buy5.85327,5001,915,87516,205,610Aug 13 07:16 PM
Redmile Group, LLC10% OwnerAug 10Buy5.81180,0001,045,80015,878,110Aug 10 08:59 PM
Redmile Group, LLC10% OwnerAug 07Buy5.67276,5431,567,99915,698,110Aug 10 08:59 PM
Redmile Group, LLC10% OwnerAug 06Buy5.85592,4503,465,83315,421,567Aug 10 08:59 PM